申请人:SmithKline Beecham Corporation
公开号:US05834469A1
公开(公告)日:1998-11-10
The invention concerns compounds of the following formulae: ##STR1## wherein the variables are defined in the specification. The compounds are useful as endothelin receptor antagonists.
本发明涉及以下式子的化合物:##STR1##
其中变量在说明书中有定义。这些化合物可用作内皮素受体拮抗剂。